The groundbreaking rise of Viagra has firmly established as a symbol of pharmaceutical success, but its position within the broader sector now raises questions about long-term returns . Generic versions are diminishing market share, leading to worries that supporting companies heavily reliant to Viagra's previous standing could be a speculative mov